January 2026

This paper evaluates the effectiveness of monoclonal antibodies (mAbs), antisense oligonucleotides (ASOs), and metal chelators for the treatment of prion diseases. Using data from current scientific journals and from biomedical research databases such as PubMed, this review compares the efficiency, ...